ANTHONY GREGG LAPOINTE
CIK 1331860 · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$599.5K
Companies
11
Total Filings
60
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | Director | 18,250 | $32.85 | $599.5K | $0 | 10 | 2026-05-19 |
| Astria Therapeutics, Inc. (ATXS) Delisted | Director | — | $12.58 | — | $0 | 6 | 2026-01-23 |
| SNGX | Director | — | $0.43 | — | $0 | 4 | 2025-06-20 |
| SOLIGENIX, INC. (SNGXW) Delisted | Director | — | $0.01 | — | $0 | 5 | 2021-09-24 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | — | $8.54 | — | $0 | 5 | 2021-06-02 |
| SCICLONE PHARMACEUTICALS INC (SCLN) Delisted | Director | — | — | — | $0 | 10 | 2017-10-16 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | — | — | — | $0 | 1 | 2017-05-24 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Director | 0 | — | — | $0 | 4 | 2016-10-26 |
| ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Director | — | — | — | $0 | 2 | 2016-06-21 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | — | — | — | $0 | 2 | 2010-01-04 |
| QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Director | — | — | — | $0 | 1 | 2007-01-04 |
Recent Filings · Page 3 of 6
60 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-15 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2019-09-10 | SOLIGENIX, INC. (SNGXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-24 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2019-02-15 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-04 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-04 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-09-28 | SOLIGENIX, INC. (SNGXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-18 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2017-11-02 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2017-10-16 | SCICLONE PHARMACEUTICALS INC (SCLN) Delisted | Disp (D) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.